ScImage inks IT deal, launches product
Los Altos, CA-based ScImage, a provider of PACS and IT solutions, has cut an agreement to install its PICOM system at El Camino Hospital in Mountain View, CA. The deal includes long-term storage of both cardiology and radiology images and information
Los Altos, CA-based ScImage, a provider of PACS and IT solutions, has cut an agreement to install its PICOM system at El Camino Hospital in Mountain View, CA. The deal includes long-term storage of both cardiology and radiology images and information using ScImage's archive and telemedicine portal, PICOMOnline. The goal of the installation is to provide to both the cardiology and radiology departments seamless access to multimodality images and information inside and outside the hospital. Earlier this month, ScImage introduced NetraMD, a virtual colonoscopy tool that supports simultaneous volumetric and endoscopic flythrough exploration of prone and supine acquisitions on the same screen.
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Study: Monitoring of Prostate MRI Exams Could Lead to 75 Percent Reduction of Gadolinium Contrast
March 17th 2025While DCE MRI was deemed helpful in over 67 percent of cases in which it was used, researchers found that monitored prostate MRI exams, which facilitated a 75 percent reduction of DCE MRI sequences, had comparable sensitivity for prostate cancer as non-monitored exams.
